However, the anti-inflammatory potential of hispidin still remain

However, the anti-inflammatory potential of hispidin still remains uncharacterized. RESULTSIn this study, the effects of hispidin on activation see more of nuclear factor kappa B (NF-B) and the subsequent production of inducible nitric oxide synthase (iNOS) were determined in the lipopolysaccharide (LPS)-induced macrophage RAW 264.7 cells. Our data indicated that hispidin inhibits transcriptional activity of NF-B

in a dose-dependent manner. Hispidin also attenuated LPS-induced NF-B nuclear translocation and associated inhibitor of kappa B (IB-) degradation. Furthermore, hispidin deceased iNOS protein expression and the generation of reactive oxygen species (ROS) in the LPS-induced cells, but did not affect phosphorylation of mitogen-activated protein kinases. CONCLUSIONThese findings suggest that hispidin exhibits anti-inflammatory activity through suppressing ROS mediated NF-B pathway in mouse macrophage cells. (c) 2014 Society of Chemical Industry”
“Background: Adenomectomy is the treatment of choice for ACTH-secreting

adenomas. Although the development of ACTH deficiency immediately after adenomectomy suggests surgical success, disease recurrence was reported in patients who developed hypocortisolism postoperatively. In the current study, we examined the value of measuring perioperative plasma ACTH and cortisol levels in predicting disease recurrence of patients with ACTH-secreting adenomas.\n\nMethods: Consecutive patients (n = 55; 41 PFTα purchase females, 14 males) with clinical, biochemical, Tipifarnib and histological documentation of ACTH-secreting adenomas were investigated after pituitary adenomectomy. All patients were followed with clinical monitoring and frequent measurements of plasma ACTH and serum cortisol levels, and none received glucocorticoids

unless or until they developed symptoms of adrenal insufficiency or when their serum cortisol levels were <= 3 mu g/dL.\n\nResults: Postoperative serum cortisol levels reached <= 3 mu g/dL in 46 of 55 and were >= 4 mu g/dL in the remaining 9. Simultaneously measured plasma ACTH levels in the latter 9 patients were >40 ng/L when the serum cortisol reached its nadir. In contrast, among the 46 patients who had serum cortisol levels of <= 3 mu g/dL, plasma ACTH levels measured simultaneously were <= 20 ng/L in 38 of 46 and >20 ng/L in the remaining 8. During a mean follow-up period of nearly 7 years, patients who had a nadir plasma ACTH of >20 ng/L developed recurrences even though their postoperative serum cortisol levels were <= 3 mu g/dL.\n\nConclusions: Despite profound hypocortisolemia after adenomectomy, a simultaneously measured plasma ACTH level of >20 ng/L in the perioperative period is highly predictive of future recurrence of ACTH-secreting adenomas.

Comments are closed.